Vivos Therapeutics, Inc. (VVOS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 42
+0.01
+1.6949%
$
2.41M Market Cap
- P/E Ratio
- Div Yield
131,500 Volume
-3.4 Eps
$ 0.41
Previous Close 
Want to track VVOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
VVOS Earnings Reports FAQ
What is the earnings per share (EPS) for VVOS?
The current EPS is -3.4.
What is the company's earnings growth rate?
Vivos Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Vivos Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Vivos Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for VVOS at this time, as Vivos Therapeutics, Inc has no recent EPS data to calculate it.
